K190230 is an FDA 510(k) clearance for the iFuse Implant System®. Classified as Sacroiliac Joint Fixation (product code OUR), Class II - Special Controls.
Submitted by SI-BONE, Inc. (Santa Clara, US). The FDA issued a Cleared decision on April 3, 2019 after a review of 56 days - a notably fast clearance cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.